UNSPSC 51202504: Procodazole ethyl ester

This classification denotes a biological response modifier C12H14N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 791487L0WH, chemically known as 1h-benzimidazole-2-propanoic acid, ethyl ester, but more generally known as procodazole ethyl ester, which bears US NIH Compound Identifier 228135. Most nations, for tariff and trade purposes, schedule procodazole ethyl ester under HS 29339990 and SITC 51577. As of Q4 2014, PROCODAZOLE ETHYL ESTER remains US FDA's Preferred Term for this commodity. SMILES: CCOC(=O)CCC1[NH]C2CCCCC2N1.

UNSPSC 51202504 Procodazole ethyl ester is a Commodity code under which state and local governments procure pharmaceutical products and medical supplies, though recent solicitations show minimal activity directly aligned with this specific chemical compound. The recent opportunities tagged to this code reflect broader pharmaceutical and medical supply acquisition across state health agencies, counties, and municipalities — including naloxone and drug deactivation systems, generic multi-source pharmaceuticals and OTC products, medical and first aid supplies for emergency response, and direct-to-manufacturer pharmacy programs. Issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire departments (City of Tampa), and cooperative purchasing alliances serving multiple state and local jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The work involves competitive procurement of pharmaceutical inventory, medical consumables, and pharmacy benefit management services rather than specialized chemical intermediates.

Geographic activity spans Florida, Texas, Minnesota, and Oregon, with MMCAP representing multi-state purchasing across participating jurisdictions. Representative recent opportunities include Seminole County's IFB 60459723LAS seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries (due July 26, 2023); the City of Tampa's IFB 26P00145 for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000 and a sheltered-market set-aside for certified Small Local Business Enterprises offering a 5 percent bid discount (due March 13, 2026); and MMCAP's RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products across multiple state and local members, due March 26, 2026. The mismatch between the code's nominal scope (a specific pharmaceutical precursor compound) and actual procurement activity (broad medical supply and pharmacy benefit services) suggests limited relevance of this Commodity code to vendors supplying the chemical itself rather than finished pharmaceuticals or medical products.